Brain targeted delivery of lurasidone HCl via nasal administration of mucoadhesive nanoemulsion formulation for the potential management of schizophrenia

References

• Abdou EM, Kandil SM, Miniawy H. 2017. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. Int J Pharm. 529:667–677.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Mir SR, Kohli K, Amin S. 2014. Effect of oil and co-surfactant on the formation of Solutol HS 15 based colloidal drug carrier by Box–Behnken statistical design. Colloids Surf A Physicochem Eng Aspects. 453:68–77.
   Web of Science ®Google Scholar
• Anton N, Vandamme TF. 2011. Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm Res. 28:978–985.
   PubMed Web of Science ®Google Scholar
• Aungst BJ. 2012. Absorption enhancers: applications and advances. AAPS J. 14:10–18.
   PubMed Web of Science ®Google Scholar
• Bachhav YG, Patravale VB. 2009. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm. 365:175–179.
   PubMed Web of Science ®Google Scholar
• Basalious EB, Abdallah AM. 2017. Phospholipid based self-nanoemulsifying self-nanosuspension (p-SNESNS) as a dual solubilization approach for development of formulation with diminished food effect: fast/fed in vivo pharmacokinetics study in human. Eur J Pharm Sci. 109:244–252.
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Gainetdinov RR. 2011. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 63:182–217.
   PubMed Web of Science ®Google Scholar
• Costall B, Naylor RJ. 1973. On the mode of action of apomorphine. Eur J Pharmacol. 21:350–361.
   PubMed Web of Science ®Google Scholar
• Crowe TP, Greenlee MHW, Kanthasamy AG, Hsu WH. 2018. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 195:44–52.
   PubMed Web of Science ®Google Scholar
• Gorain B, Choudhury H, Kundu A, Sarkar L, Karmakar S, Jaisankar P, Pal TK. 2014. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Colloids Surf B Biointerfaces. 115:286–294.
   PubMed Web of Science ®Google Scholar
• Jain R, Patravale VB. 2009. Development and evaluation of nitrendipine nanoemulsion for intranasal delivery. J Biomed Nanotechnol. 5:62–68.
   PubMed Web of Science ®Google Scholar
• Jazuli I, Annu Nabi B, Moolakkadath T, Alam T, Baboota S, Ali J. 2019. Optimization of nanostructured lipid carriers of Lurasidone hydrochloride using Box-Behnken design for brain targeting: in vitro and in vivo Studies. J Pharm Sci. 108:3082–3090.
   PubMed Web of Science ®Google Scholar
• Kotta S, Khan AW, Ansari SH, Sharma RK, Ali J. 2015. Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method. Drug Deliv. 22:455–466.
   PubMed Web of Science ®Google Scholar
• Ledet G, Pamujula S, Walker V, Simon S, Graves R, Mandal TK. 2014. Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery. Drug Dev Ind Pharm. 40:370–379.
   PubMed Web of Science ®Google Scholar
• Lochhead JJ, Thorne RG. 2012. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 64:614–628.
   PubMed Web of Science ®Google Scholar
• Lovelyn C, Attama A. 2011. Current state of nanoemulsions in drug delivery. JBNB. 02:626–639.
   Google Scholar
• McClements DJ. 2012. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter. 8:1719–1729.
   Web of Science ®Google Scholar
• Miao Y, Sun J, Chen G, Lili R, Ouyang P. 2016. Enhanced oral bioavailability of lurasidone by self-nanoemulsifying drug delivery system in fasted state. Drug Dev Ind Pharm. 42:1234–1240.
   PubMed Web of Science ®Google Scholar
• Patel MH, Mundada VP, Sawant KK. 2019. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia. Drug Dev Ind Pharm. 45:1242–1257.
   PubMed Web of Science ®Google Scholar
• Patel MR, Patel RB, Bhatt KK, Patel BG, Gaikwad RV. 2016. Paliperidone microemulsion for nose-to-brain targeted drug delivery system: pharmacodynamic and pharmacokinetic evaluation. Drug Deliv. 23:346–354.
   PubMed Web of Science ®Google Scholar
• Patel RB, Patel MR, Bhatt KK, Patel BG, Gaikwad RV. 2016a. Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration. Drug Deliv. 23:307–315.
   PubMed Web of Science ®Google Scholar
• Patel RB, Patel MR, Bhatt KK, Patel BG, Gaikwad RV. 2016b. Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study. Drug Deliv. 23:207–213.
   PubMed Web of Science ®Google Scholar
• Patel RB, Patel MR, Bhatt KK, Patel BG, Mishra A, Chutani K, Gaikwad RV, Samad A. 2013. Risperidone microemulsion for transnasal delivery: pharmacodynamic and pharmacokinetic evaluation. Pharm Nanotechnol. 1:44–53.
   Google Scholar
• Patel M, Patel R, Thakore S. 2018. Nanoemulsion in drug delivery. In: Inamuddin AMA, Ali M, editors. Applications of nanocomposite materials in drug delivery. Duxford: Woodhead Publishing; p. 667–693.
   Google Scholar
• Patel RB, Patel MR, Thakore SD, Patel BG. 2017. Nanoemulsion as a valuable nanostructure platform for pharmaceutical drug delivery. In: Grumezescu AM, editor. Nano- and microscale drug delivery systems. Amsterdam (Netherlands): Elsevier; p. 321–342.
   Google Scholar
• Patel MH, Sawant KK. 2019. Self microemulsifying drug delivery system of lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: in vitro, Caco-2 cell line and in vivo evaluation. Eur J Pharm Sci. 138:105027.
   PubMed Web of Science ®Google Scholar
• Patel RB, Vekaria KB, Patel MR. 2016c. TLC-densitometric method for quantitation of Lurasidone hydrochloride in nanoemulsion, microemulsion, for equilibrium solubility and ex vivo diffusion studies. Thai J Pharm Sci. 40:32–41.
   Google Scholar
• Porecha S, Shah T, Jogani V, Naik S, Misra A. 2009. Microemulsion based intranasal delivery system for treatment of insomnia. Drug Deliv. 16:128–134.
   PubMed Web of Science ®Google Scholar
• Salamone JD, Correa M, Mingote SM, Weber SM. 2005. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol. 5:34–41.
   PubMed Web of Science ®Google Scholar
• Samalin L, Garnier M, Llorca PM. 2011. Clinical potential of lurasidone in the management of schizophrenia. Ther Clin Risk Manag. 7:239–250.
   PubMed Web of Science ®Google Scholar
• Shah S, Parmar B, Soniwala M, Chavda J. 2016. Design, optimization, and evaluation of lurasidone hydrochloride nanocrystals. AAPS PharmSciTech. 17:1150–1158.
   PubMed Web of Science ®Google Scholar
• Shin SC, Cho CW, Oh IJ. 2001. Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int J Pharm. 222:199–203.
   PubMed Web of Science ®Google Scholar
• Shinde RL, Jindal AB, Devarajan PV. 2011. Microemulsions and nanoemulsions for targeted drug delivery to the brain. Curr Nanosci. 7:119–133.
   Web of Science ®Google Scholar
• Singh SK, Dadhania P, Vuddanda PR, Jain A, Velaga S, Singh S. 2016. Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment. RSC Adv. 6:2032–2045.
   Web of Science ®Google Scholar
• Sood S, Jain K, Gowthamarajan K. 2014. Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids Surf B Biointerfaces. 113:330–337.
   PubMed Web of Science ®Google Scholar
• Vyas TK, Babbar AK, Sharma RK, Misra A. 2005. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting. J Drug Target. 13:317–324.
   PubMed Web of Science ®Google Scholar